Literature DB >> 451459

Acute renal insufficiency occurring during intravenous desferrioxamine therapy.

R Batey, J Scott, S Jain, S Sherlock.   

Abstract

A patient of 14 years suffering from secondary haemosiderosis and thalassaemia major was treated with i.v. desferrioxamine in doses up to 3 g/d. Urine iron loss ranged from 46-158 mg/d. Despite improvement in cardiac and hepatic status the patient developed acute renal insufficiency of the pre renal type. The possible role of desferrioxamine in this complication is discussed. Desferrioxamine given s.c. or i.v. effects a marked urinary iron loss but its use may not be without significant complications.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 451459     DOI: 10.1111/j.1600-0609.1979.tb02809.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


  4 in total

1.  Acute renal failure following deferoxamine overdose.

Authors:  Salvatore Li Volti; Carmela Maccarone; Giovanni Li Volti; Maria A Romeo
Journal:  Pediatr Nephrol       Date:  2003-08-14       Impact factor: 3.714

Review 2.  Deferoxamine (desferrioxamine). New toxicities for an old drug.

Authors:  Y Bentur; M McGuigan; G Koren
Journal:  Drug Saf       Date:  1991 Jan-Feb       Impact factor: 5.606

3.  Acute renal failure following deferoxamine overdose.

Authors:  Latha Prasannan; Joseph T Flynn; John E Levine
Journal:  Pediatr Nephrol       Date:  2003-02-07       Impact factor: 3.714

Review 4.  Benefits and risks of deferiprone in iron overload in Thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine.

Authors:  George J Kontoghiorghes; Katia Neocleous; Annita Kolnagou
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.